Mechanical circulatory support devices have been approved as bridge to transplantation, as bridge to recovery, or as destination therapy to treat end-stage heart failure. The perioperative challenges for the anesthesiologist and the intensivist caring for these patients include device-related complications, hemodynamic instability, arrhythmias, right ventricular failure, and coagulopathy. Perioperative management in this high-risk population has a significant impact on patient outcomes. This review focuses immediate postoperative intensive care unit management of device-related complications.
KirklinJKNaftelDCKormosRL. Fifth INTERMACS annual report: risk factor analysis from more than 6,000 mechanical circulatory support patients. J Heart Lung Transplant. 2013;32:141-156.
3.
HesselEA2nd. Management of patients with implanted ventricular assist devices for noncardiac surgery: a clinical review. Semin Cardiothorac Vasc Anesth. 2014;18:57-70.
4.
GelijnsACRichardsAFWilliamsDLOzMCOliveiraJMoskowitzAJ. Evolving costs of long-term left ventricular assist device implantation. Ann Thorac Surg. 1997;64:1312-1319.
5.
AllenSJSidebothamD. Postoperative care and complications after ventricular assist device implantation. Best Pract Res Clin Anaesthesiol. 2012;26:231-246.
6.
KlotzSVahlhausCRiehlCReitzCSindermannJRScheldHH. Pre-operative prediction of post-VAD implant mortality using easily accessible clinical parameters. J Heart Lung Transplant. 2010;29:45-52.
7.
KhazaniePHammillBGPatelCB. Trends in the use and outcomes of ventricular assist devices among medicare beneficiaries, 2006 through 2011. J Am Coll Cardiol. 2014;63:1395-1404.
8.
StehlikJNelsonDMKfouryAG. Outcome of noncardiac surgery in patients with ventricular assist devices. Am J Cardiol. 2009;103:709-712.
9.
BrownJBHallinanWMMasseyHT. Does the need for noncardiac surgery during ventricular assist device therapy impact clinical outcome?Surgery. 2009;146:627-633.
10.
GarattiABruschiGColomboT. Noncardiac surgical procedures in patient supported with long-term implantable left ventricularassist device. Am J Surg. 2009;197:710-714.
TuzunERobertsKCohnWE. In vivo evaluation of the HeartWare centrifugal ventricular assist device. Tex Heart Inst J. 2007;34:406-411.
13.
MillerLWPaganiFDRussellSD. HeartMate II clinical investigators.use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med. 2007;357:885-896.
14.
McGeeMGParnisSMNakataniT. Extended clinical support with an implantable left ventricular assist device. ASAIO Trans. 1989;35:614-616.
15.
StanfieldJRSelzmanCH. In vitro pulsatility analysis of axial-flow and centrifugal-flow left ventricular assist devices. J Biomech Eng. 2013;135:0345051-0345056.
16.
MoazamiNKiyotakaFMarikoK. Axial and centrifugal continuous-flow rotary pumps: a translation from pump mechanics to clinical practice. J Heart Lung Transplant. 2013;32:1-11.
LundLHGabrielsenATirenL. Derived and displayed power consumption, flow, and pulsatility over a range of HeartMate II left ventricular assist device settings. ASAIO J. 2012;58:183-190.
19.
TopilskyYMaltaisSOhJK. Focused review on transthoracic echocardiographic assessment of patients with continuous axial left ventricular assist devices. Cardiol Res Pract. 2011;2011:187434.
20.
NicolosiACPagelPS. Perioperative considerations in the patient with a left ventricular assist device. Anesthesiology. 2003;98:565-570.
21.
SinghSKuschnerWGLighthallG. Perioperative intravascular fluid assessment and monitoring: a narrative review of established and emerging techniques. Anesthesiol Res Pract. 2011;2011:231493.
22.
DengMCLoebeMEl-BanayosyA. Mechanical circulatory support for advanced heart failure: effect of patient selection on outcome. Circulation. 2001;103:231-237.
23.
WeitzelNPuskasFClevelandJLeviMESeresT. Left ventricular assist device outflow cannula obstruction by the rare environmental fungus Myceliophthora thermophila. Anesth Analg. 2009;108:73-75.
24.
StulakJMDeoSSchirgerJ. Preoperative atrial fibrillation increases risk of thromboembolic events after left ventricular assist device implantation. Ann Thorac Surg. 2013;96:2161-2167.
25.
HortonSCKhodaverdianRPowersA. Leftventricular assist devicemalfunction: a systematic approach to diagnosis. J Am Coll Cardiol. 2004;43:1574-1583.
26.
ArgiriouMKolokotronSMSakellaridisT. Right heart failure post left ventricular assist device implantation. J Thorac Dis. 2014;6(suppl 1):S52-S59.
27.
AtluriPGoldstoneABFairmanAS. Predicting right ventricular failure in the modern, continuous flow left ventricular assist device era. Ann Thorac Surg. 2013;96:857-863.
28.
PrattAKShahNSBoyceSW. Left ventricular assist device management in the ICU. Crit Care Med. 2014;42:158-168.
29.
BuckleyMSFeldmanJP. Inhaled epoprostenol for the treatment of pulmonary arterial hypertension in critically ill adults. Pharmacotherapy. 2010;30:728-740.
30.
MarzecLNAmbardekarAV. Preoperative evaluation and perioperative management of right ventricular failure after left ventricular assist device implantation. Semin Cardiothorac Vasc Anesth. 2013;17:249-261.
31.
LivingstonERFisherCABibidakisEJ. Increased activation of the coagulation and fibrinolytic systems leads to hemorrhagic complications during left ventricular assist implantation. Circulation. 1996;94(9)(suppl):II227-II234.
32.
LalondeSDAlbaACRigobonA. Clinical differences between continuous flow ventricular assist devices: a comparison between HeartMate II and HeartWare HVAD. J Card Surg. 2013;28:604-610.
33.
WilhelmMJRuschitzkaFFalkV. Destination therapy: time for a paradigm change in heart failure therapy. Swiss Med Wkly. 2013;143:w13729.
34.
MahlaESuarezTABlidenKP. Platelet function measurement-based strategy to reduce bleeding and waiting time in clopidogrel-treated patients undergoing coronary artery bypass graft surgery: the timing based on platelet function strategy to reduce clopidogrel-associated bleeding related to CABG (TARGET-CABG) study. Circ Cardiovasc Interv. 2012;5:261-269.
35.
WeitzelNSWeitzelLBEppersonLEKarimpour-FordATranZVSeresT. Platelet mapping as part of modified thromboelastography (TEGĀ®) in patients undergoing cardiac surgery and cardiopulmonary bypass. Anaesthesia. 2012;67:1158-1165.
36.
LahporJKhaghaniAHetzerR. European results with a continuous-flow ventricular assist device for advanced heart-failure patients. Eur J Cardiothorac Surg. 2010;37:357-361.
37.
GeisenUHeilmannCBeyersdorfF. Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von willebrand disease. Eur J Cardiothorac Surg. 2008;33:679-684.
38.
YoungPPUziebloATrulockELublinDMGoodnoughLT. Autoantibody formation after alloimmunization: are blood transfusions a risk factor for autoimmune hemolytic anemia?Transfusion. 2004;44:67-72.
39.
PieriMAgrachevaNDi PrimaAL. Primary anticoagulation with bivalirudin for patients with implantable ventricular assist devices [published online September19, 2013]. Artif Organs.
40.
BunteMCBlackstoneEHThuitaL. Major bleeding during HeartMate II support. J Am Coll Cardiol. 2013;62:2188-2196.
41.
MajeedFKopWJPostonRSKallamSMehraMR. Prospective, observational study of antiplatelet and coagulation biomarkers as predictors of thromboembolic events after implantation of ventricular assist devices. Nat Clin Pract Cardiovasc Med. 2009;6:147-157.
42.
SchneebergerYPechaSKubikMDeuseTReichenspurnerH. New regimenforearly postoperative anticoagulation in HeartWare ventricular assist device patients: is less more?Thoraccardiovasc Surg. 2013;61:SC49.
43.
PotapovEVStepanenkoAKaufmannF. Thrombosis and cable damage in the HeartWare pump: clinical decisions and surgical technique. ASAIO J. 2013;59:37-40.
44.
FrazierOHGemmatoCMyersTJ. Initial clinical experience with the HeartMate II axial-flow left ventricular assist device. Tex Heart Inst J. 2007;34:275-281.
45.
YildirimYPechaSReichenspurnerHDeuseT. Mechanically induced ventricular tachycardia by the HeartWare ventricular assist device. ASAIO J. 2014;60(1):124-126.
46.
MartinezSCFanslerDLauJNovakELJosephSMKleigerRE. Characteristics of the electrocardiogram in patients with continuous-flow left ventricular assist devices [published online July7, 2014]. Ann Noninvasive Electrocardiol.
47.
MadiganJDChoudhriAFChenJSpotnitzHMOzMCEdwardsN. Surgical management of the patient with an implanted cardiac device: implications ofelectromagnetic interference. Ann Surg. 1999;230:639-647.
